Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -308,922 | -195,928 | -96,756 | -197,611 | -109,785 |
| Depreciation Amortization | 1,439 | 1,265 | 1,280 | 16,897 | 14,763 |
| Accounts receivable | -10,402 | -8,161 | -2,899 | -7,583 | -3,983 |
| Accounts payable and accrued liabilities | 4,043 | N/A | N/A | N/A | -593 |
| Other Working Capital | -17,347 | -23,210 | -21,109 | -24,790 | -34,104 |
| Other Operating Activity | 57,845 | 41,196 | 23,709 | -77,479 | -101,011 |
| Operating Cash Flow | $-273,344 | $-184,838 | $-95,775 | $-290,566 | $-234,713 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -52,634 | -136,981 | -98,134 | -199,577 | -274,330 |
| PPE Investments | -13,332 | -8,299 | -3,059 | -4,076 | -2,884 |
| Purchase Of Investment | -14,339 | -14,339 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 170,322 | 170,322 |
| Investing Cash Flow | $-80,305 | $-159,619 | $-101,193 | $-33,331 | $-106,892 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 363,863 | 362,959 | 353,617 | 336,853 | 324,611 |
| Financing Cash Flow | $363,863 | $362,959 | $353,617 | $336,853 | $324,611 |
| Exchange Rate Effect | -502 | -30 | -198 | -472 | -617 |
| Beginning Cash Position | 115,525 | 115,525 | 115,525 | 103,041 | 103,041 |
| End Cash Position | 125,237 | 133,997 | 271,976 | 115,525 | 85,430 |
| Net Cash Flow | $9,712 | $18,472 | $156,451 | $12,484 | $-17,611 |
| Free Cash Flow | |||||
| Operating Cash Flow | -273,344 | -184,838 | -95,775 | -290,566 | -234,713 |
| Capital Expenditure | -13,332 | -8,299 | -3,059 | -4,076 | -2,884 |
| Free Cash Flow | -286,676 | -193,137 | -98,834 | -294,642 | -237,597 |